VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25621A0023
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 14 $351,187 obligated
Award facts
- Opportunity
-
- 36C25621Q0353 Solicitation number
- Combined order value
-
- $456,596 Current, with exercised options
- $457,437 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 20% used
- $1,722,865.60
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Veterans Integrated Service Network 16 (VISN 16) of the Department of Veterans Affairs awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation for the provision of point-of-care whole blood glucose testing equipment and supplies. The contract, valued at $1,722,865.60 with an ultimate completion date of September 30, 2026, was awarded on April 1, 2021, and is issued under Roche's existing General Services Administration Schedule contract for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). No set-aside designation was applied to this procurement, reflecting open competition in the federal marketplace. Performance is conducted at Roche's facility in Castleton, Indiana, with firm fixed-price delivery pricing. Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostic products, laboratory instruments, reagents, and associated medical services for federal healthcare agencies.
The BPA vehicle provides VISN 16 facilities with a flexible procurement mechanism to acquire glucose testing devices and associated consumables on a call-as-needed basis to support point-of-care diagnostic capabilities across veteran healthcare facilities. Glucose monitoring represents a critical diagnostic function for diabetes and metabolic disease management within VA medical centers. The underlying task orders, issued annually beginning in fiscal year 2022 and continuing through 2025, demonstrate sustained utilization with individual call values ranging from approximately $5,174 to $101,830. Roche Diagnostics maintains an extensive federal contracting presence across multiple VISNs and the Defense Health Agency, positioning the company as a primary supplier of advanced diagnostic technologies to the military, veterans, and civilian healthcare systems. The firm's comprehensive federal diagnostic portfolio encompasses molecular diagnostics, clinical chemistry analysis, immunochemistry testing, histology services, point-of-care testing devices, and specialized reagents for chronic condition detection.
Task orders
Show all 14
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C25621A0023?
36C25621A0023 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on April 1, 2021.
How much is contract 36C25621A0023 worth?
Orders under 36C25621A0023 have obligated $351,187. Their combined current value, with exercised options, is $456,596. Their combined potential value, with all options, is $457,437. 36C25621A0023's own ceiling is $1,722,866.
How many orders have been placed under contract 36C25621A0023?
14 orders have been placed under 36C25621A0023, the latest on October 1, 2025.
Who can order from contract 36C25621A0023?
36C25621A0023 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C25621A0023 under another contract?
Yes. 36C25621A0023 is a blanket purchase agreement under V797P5279B, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25621A0023 competed?
The extent of competition for 36C25621A0023 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV